Stay updated on CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.

Latest updates to the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a 2024 literature citation about switching from intravenous to subcutaneous infliximab in inflammatory bowel disease. Updated the page revision to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s footer revision/version was updated from v3.5.2 to v3.5.3, indicating a web UI or backend build update rather than a change to the clinical study information.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.5.0 was added and revision: v3.4.3 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2. This is a minor software version update with no changes to the study content or visible page functionality.SummaryDifference0.1%

- Check90 days agoChange Detected- Removed 'Crohn's disease' and related topics, including MedlinePlus Genetics, from the page.SummaryDifference0.2%

Stay in the know with updates to CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.